FLX-787: Phase II started

Flex Pharma began a blinded, placebo-controlled, crossover, Australian Phase II trial

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE